Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Citeline Podcasts

Business

Episodes

Showing 301-400 of 519
«« ← Prev Page 4 of 6 Next → »»

Medtech Connect 16: AI For Cross Border Regulation

20 Jul 2024

Contributed by Lukas

In this episode, Medtech Insight senior reporter Hannah Daniel speaks to DJ Fang, chief operating officer and co-founder of Pure Global. Pure Global u...

Drug Fix Special: Why The US Approves Most New Drugs Before The EU

19 Jul 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss the impact of a US and EU drug approvals analysis that found the US FDA still clears many novel products first...

국내 AI 신약개발, 선진국과 격차 줄이려면? (Korean-language podcast)

16 Jul 2024

Contributed by Lukas

신테카바이오 조해경 사장은 Scrip과의 인터뷰에서 국내 AI  신약 개발 현황을 글로벌 흐름와 비교하고, 국내외 경...

The Importance of Exploring Genetic Potential

16 Jul 2024

Contributed by Lukas

Discover the key considerations critical to the genetic analysis for advanced therapies, including qPCR and dPCR. Don’t miss expert insights from Ch...

Scrip's Five Must-Know Things - 16 July 2024

16 Jul 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 July 2024. In this episode: Q1’s top 10 drugs; Pfize...

EPR Consultant Urges Producers To Start Collecting Packaging Data

12 Jul 2024

Contributed by Lukas

In this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended produ...

Improving Communication: The Relationship Between Biotech And Biopharma

10 Jul 2024

Contributed by Lukas

Improving Communication: The Relationship Between Biotech And Biopharma by Citeline

【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)

09 Jul 2024

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Scrip's Five Must-Know Things - 8 July 2024

08 Jul 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 July 2024. In this episode: US approval for Lilly’s A...

Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead

05 Jul 2024

Contributed by Lukas

Scrip's Joseph Haas, Mandy Jackson and Kevin Grogan discuss the biopharma dealmaking environment as we reach the midpoint of 2024. Haas reviews dealma...

Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection

05 Jul 2024

Contributed by Lukas

In this episode of the In Vivo podcast, Billy Boyle, CEO of Owlstone Medical, discusses how his company is developing several breath biopsy products f...

In Vivo Podcast Episode with Stefan Woxström

02 Jul 2024

Contributed by Lukas

In Vivo Podcast Episode with Stefan Woxström by Citeline

How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz

01 Jul 2024

Contributed by Lukas

Aspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and wh...

Scrip's Five Must-Know Things - 1 July 2024

01 Jul 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 June 2024. In this episode: global CEO remuneration; a...

Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming

28 Jun 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss what the FDA included in its long-awaited guidance on clinical trial diversity action plans, along with what w...

China Biotech Podcast - 26 June 2024 (Chinese language)

26 Jun 2024

Contributed by Lukas

Guest speaker “Angus” Shipo Xie of Hankun Law joins Brian Yang to discuss new overseas data transfer rules, while Dexter Yan explains China biotec...

Scrip's Five Must-Know Things - 24 June 2024

24 Jun 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 June 2024. In this episode: the outlook for 2025 launc...

Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB

21 Jun 2024

Contributed by Lukas

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technol...

The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley

17 Jun 2024

Contributed by Lukas

In this episode, HBW Insight chats with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness. “Inspired by a ...

Scrip's Five Must-Know Things - 17 June 2024

17 Jun 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 June 2024. In this episode: Boehringer best in MASH?; ...

Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond

14 Jun 2024

Contributed by Lukas

In this podcast, Janelle Hart, Managing Editor, Citeline, joins industry experts Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Asso...

June 2024 Datamonitor Healthcare Podcast: ASCO 2024

14 Jun 2024

Contributed by Lukas

The oncology team from Datamonitor Healthcare and healthcare journalist, Alaric, provide broad analytical coverage of key highlights from the ASCO 202...

China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)

14 Jun 2024

Contributed by Lukas

Guest speaker, US-based Pink Sheet senior writer Sarah Karlin-Smith, joins Brian Yang and Dexter Yan in China to discuss the recent BIO Conference, up...

ASCO 결산: 암 연구의 미래는? (Korean-language podcast)

13 Jun 2024

Contributed by Lukas

글로벌 제약업계는 암 연구의 미래를 어떻게 보고 있을까? Scrip의 ASCO 현장 취재 기사를 요약한 내용입니다. https:...

Scrip's Five Must-Know Things - 10 June 2024

10 Jun 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 June 2024. In this episode: BIO Notebook; ASCO roundup;...

The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents

07 Jun 2024

Contributed by Lukas

Generics Bulletin's editorial team discusses the latest strategic developments for major industry players Teva, Sandoz and Sawai, as well as explainin...

China Biotech Podcast - 5 June 2024 (Chinese language)

05 Jun 2024

Contributed by Lukas

Guest speaker Guangzuo Luo, chief scientific officer of Bioncetech, joins China-based editors Brian Yang and Dexter Yan in this episode, which looks a...

JB CEO On CDMO Growth, Red Sea Crisis And More

04 Jun 2024

Contributed by Lukas

In an interview with Scrip, JB CEO Nikhil Chopra addresses rumours of a sale of a stake in the Indian pharma/CDMO company by private equity fund KKR, ...

Scrip's Five Must-Know Things - 3 June 2024

03 Jun 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 May 2024. In this episode: ASCO preview; Asahi’s US ...

The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse

31 May 2024

Contributed by Lukas

An interview with Genmab’s Jan van de Winkel to mark 25 years of the company, and 20 years of the Scrip Awards. A brief history of the antibody-foc...

How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone

31 May 2024

Contributed by Lukas

In this episode we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly...

Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions

31 May 2024

Contributed by Lukas

Advancing Investigational New Drugs (INDs) can be a complex process, especially for smaller companies. Listen to your free podcast now as Marcus Delat...

'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation

29 May 2024

Contributed by Lukas

Astellas Pharma’s chief commercial officer, Claus Zieler, discusses the biopharma industry’s responsibility to drive change in health care.

China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen

28 May 2024

Contributed by Lukas

NeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She...

Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese)

28 May 2024

Contributed by Lukas

As the 15 July entry deadline for the 3rd edition of the annual Citeline Japan Awards approaches, join us in this bilingual English/Japanese podcast t...

Scrip's Five Must-Know Things - 27 May 2024

27 May 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 May 2024. In this episode: Biogen’s immunology acqui...

Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock

24 May 2024

Contributed by Lukas

Pink Sheet editors discuss the US FDA’s consideration of regulatory changes to promote innovative clinical trial designs (:32), an NIH proposal to r...

【3分で解説 世界のファーマ】第18回 GLP-1を超える肥満治療薬のカギとは?(Japanese-language podcast)

23 May 2024

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing

22 May 2024

Contributed by Lukas

In this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio company Closed Loop Medicine, discusses how his company is pairin...

Leading PRO Discusses Plans For Administering State EPR Programs

21 May 2024

Contributed by Lukas

In this episode, HBW chats with John Hite of the leading producer responsibility organization administering three Extended Producer Responsibility law...

개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast)

21 May 2024

Contributed by Lukas

빅파마 기업들의 블록버스터 신약 확보 전략에 대한 Scrip 기사를 요약한 내용입니다. https://scrip.citeline.com/SC150256/D...

How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane

20 May 2024

Contributed by Lukas

In this episode, HBW Insight catches up with Albert Swane, founder and CEO of Dutch consumer healthcare firm, TheOTCLab, to talk about business strate...

Scrip's Five Must-Know Things - 20 May 2024

20 May 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 May 2024. In this episode: the life of a blockbuster; ...

Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation

17 May 2024

Contributed by Lukas

Pink Sheet editors and reporter consider the implications of the BIOSECURE Act as it advances through a House committee (:30), whether industry would ...

May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma

17 May 2024

Contributed by Lukas

Flora gives an overview of the budding landscape of neoadjuvant therapy in melanoma and provides insight on the nuances of this market. Apple Podcast...

China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)

15 May 2024

Contributed by Lukas

In this bilingual Chinese- and English-language edition, China-based editors Brian Yang and Dexter Yan, along with guest speaker Derrick Gingery from ...

Scrip's Five Must-Know Things - 13 May 2024

13 May 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 May 2024. In this episode: AstraZeneca’s Vaxzevria f...

Episode 15: Digital Trust

09 May 2024

Contributed by Lukas

In this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the Briti...

Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta

07 May 2024

Contributed by Lukas

In this episode, HBW Insight chats with sustainable packaging expert Tony Perrotta about why it’s so difficult to replace plastic pill packs in medi...

Scrip's Five Must-Know Things - 7 May 2024

07 May 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 3 May 2024. In this episode: Japan’s Ono buys US oncolo...

Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review

03 May 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss what an upcoming listening session means for the FDA’s advisory committee reform effort (:32), the agency’...

Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch

30 Apr 2024

Contributed by Lukas

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights key interviews with Philips’ CEO Roy Jakobs on NAM’s draft fr...

April Datamonitor Podcast 2024: AAN coverage

30 Apr 2024

Contributed by Lukas

Flora and Emma are joined by Datamonitor’s CNS analysts Summer, Joseph, and Wen-Yu to discuss coverage from AAN. Other platforms (in addition to So...

Scrip's Five Must-Know Things - 30 April 2024

30 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 April 2024. In this episode: 2023’s top selling drug...

2024 Global Generics & Biosimilars Awards

29 Apr 2024

Contributed by Lukas

2024 Global Generics & Biosimilars Awards by Citeline

Podcast: Facilitating Patient Monitoring in CAR-T Development

29 Apr 2024

Contributed by Lukas

Learn how molecular technology is enhancing patient safety for CAR-T clinical trials. US FDA recently initiated class safety labeling changes after ...

Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics

26 Apr 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation (:34), upc...

Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session

26 Apr 2024

Contributed by Lukas

Pulmonologist Bing Xue, MD, reviews the latest GOLD guidelines and discusses relevant topics regarding COPD treatment.

China Biotech Podcast - 26 April 2024 (Chinese and English Language)

26 Apr 2024

Contributed by Lukas

Join Scrip's China-based editors Brian Yang and Dexter Yan in this Chinese/English podcast as they look at data presented to AACR by Chinese pharma fi...

Future Governance & Oversight of the EU Medtech Regulatory System

24 Apr 2024

Contributed by Lukas

Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadl...

Citeline - Cerba Research Podcast V2

23 Apr 2024

Contributed by Lukas

Citeline - Cerba Research Podcast V2 by Citeline

Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics

23 Apr 2024

Contributed by Lukas

Scrip's Joseph Haas, Kevin Grogan and Edwin Elmhirst talk about the biopharma M&A environment and which companies might look particularly appealing to...

Turning That Frown Upside Down: Treating Depression With Facial Botox Injections

22 Apr 2024

Contributed by Lukas

In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumati...

Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal

22 Apr 2024

Contributed by Lukas

Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal “Consumers are rewriting the rules when it comes to wher...

Scrip's Five Must-Know Things - 22 April 2024

22 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 April 2024. In this episode: Teva’s immunology biosi...

Drug Fix: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

19 Apr 2024

Contributed by Lukas

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi (:28), Janet Woodcock’s new post-FDA role (12:28), ...

Next-Generation Diagnostics: "Breathomics" From Imspex

19 Apr 2024

Contributed by Lukas

A new diagnostic technology to screen and triage individuals based on breath.

Ratio Therapeutics On BMS Buy-In, Radiopharma R&D Trends, AI And Assets

16 Apr 2024

Contributed by Lukas

Scrip’s senior editor Vibha Ravi speaks with Jack Hoppin, CEO and chairman, and John Babich, chief scientific officer, at Ratio Therapeutics, about ...

China Biotech Podcast (Chinese- and English-language) - April 2024

15 Apr 2024

Contributed by Lukas

In this Chinese- and English-language episode, guest speaker Treehill Partners co-founder Ali Parshadezah joins Brian Yang and Dexter Yan to discuss u...

Scrip's Five Must-Know Things - 15 April 2024

15 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 April 2024. In this episode: the shifting sands of pha...

Drug Fix: US FDA Adcomm Open Public Hearings, Clinical Trial Diversity Plans, Stealth’s Elamipretide

12 Apr 2024

Contributed by Lukas

Pink Sheet reporter and editors discuss Richard Pazdur’s call for more diverse opinions in FDA advisory committee meeting open public hearings (:36)...

In Conversation With 2024 In Vivo Rising Leader, Hanadie Yousef

09 Apr 2024

Contributed by Lukas

In this episode, In Vivo speaks to 2024 Rising Leader Hanadie Yousef, CEO of Juvena Therapeutics, about her journey, the secretome as a source of ther...

Scrip's Five Must-Know Things - 8 April 2024

08 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 April 2024. In this episode: Genmab buys into ADCs; Roi...

Drug Fix: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA

05 Apr 2024

Contributed by Lukas

Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial ...

Medtech Connect Episode 14: Live From HIMSS 2024

03 Apr 2024

Contributed by Lukas

In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to industry professionals at the Healthcare Information and Management Syste...

피노바이오, 국내 ADC 생태계 발전에 기여할 것 (Korean-language podcast)

02 Apr 2024

Contributed by Lukas

기술 수요와 공급의 '불균형' 속에서 국내 ADC 업체들은 생태계를 발전시키려 노력하고 있습니다.  Scrip의 정두영 ...

Scrip's Five Must-Know Things - 1 April 2024

01 Apr 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Merck & Co progresses cardiovascular str...

Analysing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen

28 Mar 2024

Contributed by Lukas

In this episode, HBW Insight’s Europe and US editors Tom Gallen and Malcolm Spicer bring their expertise to bear on the current the trend towards st...

March Datamonitor Podcast 2024: The US Inflation Reduction Act

27 Mar 2024

Contributed by Lukas

Flora and Ian are joined by Datamonitor’s financial analyst Abby, who discusses the Inflation Reduction Act and drug pricing trends in the US. Other...

Scrip's Five Must-Know Things - 26 March 2024

26 Mar 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: another big deal in radiopharmaceuticals...

Drug Fix: Mifepristone And Misinformation At SCOTUS, Understanding US FDA’s ODAC

22 Mar 2024

Contributed by Lukas

Pink Sheet reporters and editor discuss the upcoming US Supreme Court arguments on mifepristone access (:34), the SCOTUS reaction to the fight against...

China Biotech Podcast (Chinese language) - March 2024

22 Mar 2024

Contributed by Lukas

Guest speaker Kevin Duan joins Brian Yang and Dexter Yan to discuss the proposed US BIOSECURE Act, the US FDA's approval of a China-origin anti-PD-1 d...

Digital Health Roundup: EU’s AI Act Impact; Verily's Andrew Trister’s Vision For Personal AI Agent

20 Mar 2024

Contributed by Lukas

Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode: In Five Years, People Will Navigat...

Scrip's Five Must-Know Things - 18 March 2024

18 Mar 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Galderma prepares to take on Dupixent; P...

How AI Is Revolutionizing Personalized Wellness, With Bioniq’s Marni Allen

15 Mar 2024

Contributed by Lukas

In this episode, HBW Insight dives into personalized wellness with Marni Allen, chief marketing officer at tailored supplements manufacturer Bioniq. N...

【3分で解説 世界のファーマ】第17回 LSDで不安症を治療 第III相開始へ (Japanese-language podcast)

13 Mar 2024

Contributed by Lukas

Summary: 今回取り上げた記事はこちら 「MindMed Ready To Take LSD Therapy Into Phase III For Anxiety(MindMed、LSD療法を不安症治療...

"Identifying The 80% Of Undiagnosed And Misdiagnosed Patients"

11 Mar 2024

Contributed by Lukas

Vibhor Gupta, director and founder of Pangaea Data, talks to In Vivo about the value of identifying the 80% of patients with undiagnosed or misdiagnos...

Scrip's Five Must-Know Things - 11 March 2024

11 Mar 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer won’t split, for now; Pfizer’s...

Drug Fix: Vanda Appeals US FDA Jet Lag Denial In Court, Mark Cuban Battles PBMs, Austere FDA Budget

08 Mar 2024

Contributed by Lukas

Pink Sheet reporters and editor discuss Vanda’s decision to sue the FDA over the rejection of the Hetlioz jet lag indication (:30), Mark Cuban’s c...

Scrip이 묻다: 2024년 제약바이오업계 전망은? 치료영역의 발전 (Korean-language podcast)

07 Mar 2024

Contributed by Lukas

2024년 글로벌 전문가들이 예측하는 치료영역의 발전은 무엇인 지에 대한 Scrip 기사를 요약한 내용입니다 https://scr...

Medtech Connect Episode 13: Augmented Reality In Surgery

07 Mar 2024

Contributed by Lukas

In this episode, US regulatory reporter Hannah Daniel speaks to Ocutrx CEO Michael Freeman about augmented reality in medical products and their not-s...

Scrip's Five Must-Know Things - 4 March 2024

04 Mar 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: optimistic outlook for biopharma IPOs; B...

Cardio Conversations: iRhythm CEO Blackford Talks AI Arrhythmia Diagnostics

04 Mar 2024

Contributed by Lukas

iRhythm CEO Quentin Blackford returns to Medtech Insight’s Cardio Conversations podcast to talk about the launch of the company’s new Monitor long...

The Emerging Benefits Of ‘Beauty-From-Within,’ Featuring Kenvue’s Paul LaTerra

01 Mar 2024

Contributed by Lukas

In this episode of Over the Counter, HBW Insight speaks to Paul LaTerra, Director, R&D, Global Hair and Scalp for Kenvue, a New Jersey-based consumer ...

February Datamonitor Podcast: 2024 Clinical Outlook

28 Feb 2024

Contributed by Lukas

Emma and Flora outline expected trends and exciting upcoming events across therapy areas for 2024, straight from the subject matter experts at Datamon...

NodThera On The Role Of The Brain In Driving Chronic Disease

28 Feb 2024

Contributed by Lukas

Alan Watt, CEO of NodThera, a clinical-stage biotech developing brain-penetrant NLRP3 inflammasome inhibitors to treat chronic inflammatory diseases, ...

Scrip's Five Must-Know Things - 26 February 2024

26 Feb 2024

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Bayer takes strategic steps to cut debt;...

Drug Fix: US FDA And Psychedelic Drugs, Aduhelm Clinical Trial Data, Adcomm Candidates

23 Feb 2024

Contributed by Lukas

Pink Sheet reporters and editors discuss the FDA’s approach to psychedelic drugs (:25), whether postmarket clinical trial data from the Alzheimer’...

AESGP’s 60th Birthday Celebrations In 2024 Including Annual Meeting, With Jurate Švarcaite

20 Feb 2024

Contributed by Lukas

The Association of the European Self-Care Industry celebrates its 60th birthday this year. In this episode, we catch up with AESGP director general, J...

Drug Fix: Price Negotiation Suit Tossed, Drug Shortage Probe, FDA-Approved Marijuana

16 Feb 2024

Contributed by Lukas

Pink Sheet reporters and editors discuss the dismissal of PhRMA’s suit challenging the Medicare price negotiation provisions (:30), the US FTC and H...

«« ← Prev Page 4 of 6 Next → »»